FDA Inspection
Taro Pharmaceuticals U.S.A., Inc.FDA Inspection 907479 - Taro Pharmaceuticals U.S.A., Inc. - December 19, 2014
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals U.S.A., Inc., with an inspection on December 19, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 19, 2014
- Product Type
- Drugs
View Company Profile
ID · ef2048de-21e9-4aee-b9d7-0d02e3321f61
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 907479
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Taro Pharmaceuticals U.S.A., Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Taro Pharmaceuticals U.S.A., Inc.
- FDA Inspection 1066575 - 2018-08-27
- FDA Inspection 827465 - 2013-04-18
- FDA Inspection 769594 - 2012-03-08
- FDA Inspection 592198 - 2009-05-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.